Award of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG)

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000479229-2017-06-30T00:00:00Z",
    "date": "2017-06-30T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000479229",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-3",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Hazel Johnstone",
                "email": "hazel.johnstone@nhs.net",
                "telephone": "+44 1698794561",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.htmlh"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-11",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "email": "laura.santi@nhs.net",
                "telephone": "+44 1698794410",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
        "id": "org-11"
    },
    "tender": {
        "id": "NP32617",
        "title": "Award of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG)",
        "description": "Supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG). This framework has been awarded in four (4) categories, each of which is identified as a \"Lot\" as detailed in the contract notice. The Lots are as follows:- Lot 1 - Human Normal Intravenous Immunoglobulin 5% Lot 2 - Human Normal Intravenous Immunoglobulin 10% Lot 3 - Human Normal Intravenous Immunoglobulin for Subcutaneous Use Lot 4 - Subcutaneous Immunoglobulin with Hyaluronidase All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33141520",
                        "scheme": "CPV"
                    },
                    {
                        "id": "33651520",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "id": "33141520",
                        "scheme": "CPV"
                    },
                    {
                        "id": "33651520",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "id": "33141520",
                        "scheme": "CPV"
                    },
                    {
                        "id": "33651520",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "3"
            },
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "id": "33141520",
                        "scheme": "CPV"
                    },
                    {
                        "id": "33651520",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "4"
            }
        ],
        "value": {
            "amount": 78000000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "tenderPeriod": {
            "endDate": "2017-03-27T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2017-03-27T12:00:00Z"
        },
        "documents": [
            {
                "id": "FEB274620",
                "documentType": "contractNotice",
                "title": "Supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG)",
                "description": "This Framework Agreement is for the supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG). The Goods have been split into four (4) categories, each of which is identified as a \"Lot\". The Lots are as follows:- Lot 1 - Human Normal Intravenous Immunoglobulin 5% Lot 2 - Human Normal Intravenous Immunoglobulin 10% Lot 3 - Human Normal Intravenous Immunoglobulin for Subcutaneous Use Lot 4 - Subcutaneous Immunoglobulin with Hyaluronidase All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB274620",
                "format": "text/html"
            },
            {
                "id": "JUL288040",
                "documentType": "awardNotice",
                "title": "Award of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG)",
                "description": "Supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG). This framework has been awarded in four (4) categories, each of which is identified as a \"Lot\" as detailed in the contract notice. The Lots are as follows:- Lot 1 - Human Normal Intravenous Immunoglobulin 5% Lot 2 - Human Normal Intravenous Immunoglobulin 10% Lot 3 - Human Normal Intravenous Immunoglobulin for Subcutaneous Use Lot 4 - Subcutaneous Immunoglobulin with Hyaluronidase All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL288040",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "title": "Human Normal Intravenous Immunoglobulin 5%",
                "description": "Supply of Human Normal Intravenous Immunoglobulin 5%, across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot has been awarded as a Ranked Multi Supplier Framework.",
                "status": "complete",
                "value": {
                    "amount": 4450000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 720
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
                }
            },
            {
                "id": "2",
                "title": "Human Normal Intravenous Immunoglobulin 10%",
                "description": "Supply of Human Normal Intravenous Immunoglobulin 10%, across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot has been awarded as a Ranked Multi Supplier Framework.",
                "status": "complete",
                "value": {
                    "amount": 60000000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 720
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
                }
            },
            {
                "id": "3",
                "title": "Human Normal Intravenous Immunoglobulin for subcutaneous use",
                "description": "Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot has been awarded as a Ranked Multi Supplier Framework.",
                "status": "complete",
                "value": {
                    "amount": 13550000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 720
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
                }
            },
            {
                "id": "4",
                "title": "Subcutaneous Immunoglobulin with Hyaluronidase",
                "description": "Supply of Subcutaneous Immunoglobulin with Hyaluronidase. The Authority has awarded all presentations within this Lot to a single supplier.",
                "status": "complete",
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 720
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
                }
            }
        ],
        "lotDetails": {
            "maximumLotsBidPerSupplier": 2147483647
        },
        "bidOpening": {
            "date": "2017-03-27T12:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.",
                    "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes."
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true,
            "frameworkAgreement": {
                "maximumParticipants": 6
            }
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false
    },
    "language": "EN",
    "description": "The estimated values referred to in this notice cover the initial twenty-four (24) months duration of the Framework Agreement and the full twenty-four (24) months extension options. (SC Ref:501228)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000479229"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000479229"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "NP32617-1",
            "title": "Subcutaneous Immunoglobulin with Hyaluronidase",
            "relatedLots": [
                "4"
            ]
        },
        {
            "id": "NP32617-2",
            "title": "Human Normal Intravenous Immunoglobulin 10%",
            "relatedLots": [
                "2"
            ]
        },
        {
            "id": "NP32617-3",
            "title": "Human Normal Intravenous Immunoglobulin 5%",
            "relatedLots": [
                "1"
            ]
        },
        {
            "id": "NP32617-4",
            "title": "Human Normal Intravenous Immunoglobulin for subcutaneous use",
            "relatedLots": [
                "3"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP32617-1",
            "awardID": "NP32617-1",
            "title": "Subcutaneous Immunoglobulin with Hyaluronidase",
            "status": "active",
            "dateSigned": "2017-05-30T00:00:00Z"
        },
        {
            "id": "NP32617-2",
            "awardID": "NP32617-2",
            "title": "Human Normal Intravenous Immunoglobulin 10%",
            "status": "active",
            "dateSigned": "2017-05-30T00:00:00Z"
        },
        {
            "id": "NP32617-3",
            "awardID": "NP32617-3",
            "title": "Human Normal Intravenous Immunoglobulin 5%",
            "status": "active",
            "dateSigned": "2017-05-30T00:00:00Z"
        },
        {
            "id": "NP32617-4",
            "awardID": "NP32617-4",
            "title": "Human Normal Intravenous Immunoglobulin for subcutaneous use",
            "status": "active",
            "dateSigned": "2017-05-30T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2017/S 039-070527"
        }
    ]
}